Market Overview

Benchmark Company Reiterates Buy Rating, $33 PT on Progress Software Corporation

Related PRGS
Earnings Scheduled For September 27, 2017
Mid-Afternoon Market Update: Sage Therapeutics Drops After Brexanolone Drug Fails Phase III Testing; Aldeyra Therapeutics Shares Gain

In a report published Wednesday, Benchmark Company reiterated its Buy rating and $33.00 price target on Progress Software Corporation (NASDAQ: PRGS).

Benchmark Company noted, “We expect PRGS to meet our revenue and operating margin targets of $90 million and 27% for the core business when the Company reports F4Q12 results in early January. While ISV checks suggest ongoing macro concerns in financial services and Europe, we believe our numbers are sufficiently low to offset these headwinds. Even though we are comfortable with our estimates, we think there's limited upside to our numbers due to operational disruptions from restructuring activities, non-core product line divestitures and the unexpected departure of its former CEO.”

Progress Software Corporation closed on Tuesday at $21.18.

Latest Ratings for PRGS

Sep 2016Ladenburg ThalmannDowngradesBuyNeutral
Oct 2015WedbushMaintainsNeutral
Jun 2015Sidoti & Co.Initiates Coverage onNeutral

View More Analyst Ratings for PRGS
View the Latest Analyst Ratings

Posted-In: Benchmark CompanyAnalyst Color Reiteration Analyst Ratings


Related Articles (PRGS)

View Comments and Join the Discussion!

Partner Center